• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 28, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Cancer detection with sugar molecules

Bioengineer by Bioengineer
August 14, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: (Picture: Workgroup Seibel, VCH-Wiley)

Galectins are a family of proteins that have become a promising source of cancer research in recent years. A representative thereof is galectin-1. It sits on the surface of all human cells; on tumor cells, however, it occurs in enormous quantities. This makes it an interesting target for diagnostics and therapy.

"Among other things, it is known that galectin-1 hides the tumor cells from the immune system," explains Professor Jürgen Seibel of the Institute of Organic Chemistry at the Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany. Recent studies have shown that when Galectin-1 is blocked, the immune system can recognize the tumor and attack it with T cells.

Sugar molecule with docking station

No wonder, therefore, that galectin-1 has become a major focus of research. Seibel and his colleague Dr. Clemens Grimm is interested in a very specific section of this protein, the so-called carbohydrate recognition domain. They have now designed a complex sugar molecule that fits perfectly into this domain, as the scientists report in journal ChemBioChem.

"We have equipped the sugar molecule with a docking site, for example, to connect it with a fluorescent dye or an drug," says Seibel. In addition, the scientists have described the binding of their molecule to galectin-1 with high-resolution X-ray structure analyzes.

"Our findings can serve the development of high-affinity ligands of the protein Galectin-1 and thus of new drugs," said Clemens Grimm.

Quick test for Galectin-1 in progress

Now the JMU scientists are working on a rapid test for the detection of galectin-1. It is designed to enable early detection of tumors such as neuroblastoma. For the future, Seibel's team would like to expand the sugar molecules into a kind of shuttle system that allows pharmaceutical agents to be transported directly to the tumors.

###

Media Contact

Jürgen Seibel
[email protected]
49-931-318-5326
@Uni_WUE

https://www.uni-wuerzburg.de/

Original Source

https://www.uni-wuerzburg.de/en/sonstiges/meldungen/detail/artikel/mit-zuckermolekuelen-tumore-aufspueren/ http://dx.doi.org/10.1002/cbic.201700251

Share15Tweet7Share2ShareShareShare1

Related Posts

Precise Assembly of Nanopore Sequencing in Pathogenic Bacteria

Precise Assembly of Nanopore Sequencing in Pathogenic Bacteria

August 28, 2025
Tiny Fossils Reveal Major Insights into Arthropod Evolution

Tiny Fossils Reveal Major Insights into Arthropod Evolution

August 28, 2025

MicroRNA-25-3p Boosts Pancreatic Cancer Progression via EVs

August 28, 2025

Exploring Histopathology in Peste des Petits Ruminants

August 28, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    149 shares
    Share 60 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    82 shares
    Share 33 Tweet 21

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

4-Year Outcomes of Fecal Transplants in Obese Teens

Adapting Dryland Maize to Climate via Cultivars

Revolutionizing Synthetic Cells: Protein Design Breakthroughs

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.